| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis
|
Ross, David M.
|
|
|
9 |
16 |
p. 4195-4205
|
artikel
|
| 2 |
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
|
Tsilifis, Christo
|
|
|
9 |
16 |
p. 4126-4135
|
artikel
|
| 3 |
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept
|
Koura, Divya
|
|
|
9 |
16 |
p. 4336-4344
|
artikel
|
| 4 |
Asciminib in late-line CML treatment
|
Sweet, Kendra
|
|
|
9 |
16 |
p. 4317-4318
|
artikel
|
| 5 |
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL
|
Mauro, Michael J.
|
|
|
9 |
16 |
p. 4248-4259
|
artikel
|
| 6 |
Avoid burning bridges before CAR-T therapy in myeloma
|
Reddi, Swetha
|
|
|
9 |
16 |
p. 4232-4234
|
artikel
|
| 7 |
Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma
|
Heestermans, Robbe
|
|
|
9 |
16 |
p. 4306-4310
|
artikel
|
| 8 |
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma
|
Frenking, Jan H.
|
|
|
9 |
16 |
p. 4151-4166
|
artikel
|
| 9 |
Cortisol in sickle cell disease: a systematic review and meta-analysis
|
Prussien, Kemar V.
|
|
|
9 |
16 |
p. 4136-4150
|
artikel
|
| 10 |
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens
|
Matteucci, Claudia
|
|
|
9 |
16 |
p. 4265-4278
|
artikel
|
| 11 |
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis
|
Muchtar, Eli
|
|
|
9 |
16 |
p. 4311-4316
|
artikel
|
| 12 |
Genome-wide association study of somatic GATA1s mutations in newborns with Down syndrome
|
Li, Yunqi
|
|
|
9 |
16 |
p. 4235-4243
|
artikel
|
| 13 |
IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia
|
Hui, Lijun
|
|
|
9 |
16 |
p. 4217-4231
|
artikel
|
| 14 |
Impact of concomitant azoles on ruxolitinib treatment in patients with GVHD: post hoc analyses of REACH2 and REACH3
|
Mahmoudjafari, Zahra
|
|
|
9 |
16 |
p. 4206-4216
|
artikel
|
| 15 |
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders
|
Serna, Ángel
|
|
|
9 |
16 |
p. 4180-4189
|
artikel
|
| 16 |
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
|
Little, Jessica S.
|
|
|
9 |
16 |
p. 4190-4194
|
artikel
|
| 17 |
Long-term outcomes of patients with refractory cytopenia of childhood under observation only
|
Drexler, Beatrice
|
|
|
9 |
16 |
p. 4279-4285
|
artikel
|
| 18 |
One for the ages: impact of age on international prognostic indices in lymphoid cancer
|
Brieghel, Christian
|
|
|
9 |
16 |
p. 4260-4264
|
artikel
|
| 19 |
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement
|
Muhsen, Ibrahim N.
|
|
|
9 |
16 |
p. 4081-4089
|
artikel
|
| 20 |
Peripheral neuropathy and BTKis in Waldenström: a response?
|
Briani, Chiara
|
|
|
9 |
16 |
p. 4319-4320
|
artikel
|
| 21 |
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS
|
DeZern, Amy E.
|
|
|
9 |
16 |
p. 4090-4099
|
artikel
|
| 22 |
Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome
|
Esefeld, Max
|
|
|
9 |
16 |
p. 4323-4335
|
artikel
|
| 23 |
Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome
|
Andersen, Sarah
|
|
|
9 |
16 |
p. 4167-4179
|
artikel
|
| 24 |
RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome
|
Wiseman, Thomas
|
|
|
9 |
16 |
p. 4244-4247
|
artikel
|
| 25 |
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas
|
Ford, Josie G.
|
|
|
9 |
16 |
p. 4286-4305
|
artikel
|
| 26 |
SGLT2i-associated erythrocytosis: closing the evidence gap
|
Chin-Yee, Benjamin
|
|
|
9 |
16 |
p. 4321-4322
|
artikel
|
| 27 |
Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets
|
Smith, Alexis N.
|
|
|
9 |
16 |
p. 4111-4125
|
artikel
|
| 28 |
Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results
|
Shadman, Mazyar
|
|
|
9 |
16 |
p. 4100-4110
|
artikel
|
Tijdschrift beschrijving